We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Agilent Receives Expanded FDA Approval for Use of Companion Diagnostic in Identifying Gastric Cancer

Product News   Sep 25, 2017

 
Agilent Receives Expanded FDA Approval for Use of Companion Diagnostic in Identifying Gastric Cancer

Image Credit: Agilent Technologies

 
 
FURTHER INFORMATION
 
 
 

Related Product News

IncellDx Launches BioINK PD-L1 CTC Core Kit with Lyophilized CTC Control Cells for Microfluidic Liquid Biopsies

Product News

IncellDx has launched a complete, pre-optimized kit to identify, enumerate, and quantify the important tumor therapeutic target PD-L1 on circulating tumor cells (CTCs).

READ MORE

True Health Introduces New MMRV Tests

Product News

True Health announced the addition of Measles, Mumps, Rubella, and Varicella (MMRV) tests as part of its new Infectious Disease category. The launch occurred earlier this month as another component of True Health’s foundational diagnostic offering.

READ MORE

QIAGEN’s CareHPV™ Test Wins WHO Prequalification Status for Cervical Cancer Screening

Product News

Advancing science and healthcare in a region with increasing demands for modern molecular testing solutions.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE